Back to ABIVAXInsider 
Company
TRUFFLE CAPITAL SAS — ABIVAX
Filing 2023DD920130Published 7 Sept 2023France public disclosures
InitialCorrected
InitialCorrected
Not used in calculations
Corrected by filing:fr:amf:2023DD926614
Summary
TRUFFLE CAPITAL SAS
Philippe Pouletty, Membre du conseil d'administration
ABIVAX
Last 12 months
- Transactions
- Not available
- Total reported value
- Not available
CompanyABIVAX
ISINFR0012333284
Last 12 months
- Transactions
- Not available
- Total reported value
- Not available
Reported buys
€0.00
Reported sales
€3,101,480.01
Net buy/sell
-€3,101,480.01
Other reported value
€0.00
Gross reported value
€3,101,480.01
Transactions
1
Transactions
| Execution date | Direction | Nature | Instrument | Settlement | Quantity | Unit price | Total | Venue |
|---|---|---|---|---|---|---|---|---|
| 12 Jul 2023 | SellCession / SELL | DISPOSAL | SHARE | UNKNOWN | 16.088 | €192,781.00 | €3,101,480.01 | XPAR |
Sell
Execution date12 Jul 2023Cession / SELL
DISPOSAL · SHARE · UNKNOWN · XPAR
- Quantity
- 16.088
- Unit price
- €192,781.00
- Total
- €3,101,480.01
Evidence
- AMF · France2023DD920130
Corrections
Identify the affected field and a source that supports the correction. Use the private contact for rights requests; do not attach identity documents unless necessary and requested.